The global injection pen market is set to witness a growth rate of 7% in the next 5 years. Rising prevalence of chronic diseases, patient convenience and ease of use, technological advancements, ...

As semaglutide hits pharmacy shelves for $499, doctors weigh the pros and cons of brand-name vs. compounded meds.

Stacey Dooley has opened up about undergoing emergency surgery after suffering an ectopic pregnancy with her partner Kevin Clifton last year. Ectopic pregnancy is the leading cause of maternal death ...

The man convicted of attempting to assassinate President Trump while he golfed last year in South Florida tried to stab himself with a pen after a federal jury handed down the guilty verdict Tuesday ...

When data for this report was extracted on 15 July 2025, 454 patient safety incidents on the StEIS system were designated by their reporters as Never Events and had a reported incident date between ...

There has been controversy surrounding President Donald Trump's State Visit to the UK this week. But for King Charles, the event provides him with the chance to meet with his friend and penpal, ...

Wegovy (semaglutide) is a brand-name injection prescribed to help with weight loss and long-term weight management in certain people. This article covers topics such as cost, side effects, and how ...

Does compounded Semaglutide work for weight loss? Compounded semaglutide can be an affordable alternative to brand-name weight loss injections like Ozempic and Wegovy. But it’s important to understand ...

South Dakota Attorney General Marty Jackley says the state stopped a "conspiracy" to distribute drugs and other contraband items into the state's largest prison. Five people, including one former ...

A HIGHER 'golden dose' of Wegovy than is currently approved is safe and could be more effective - helping patients lose nearly a fifth of their body weight. The once-weekly injection containing the ...

Novo Nordisk A/S plans to seek US regulatory approval for a high-dose version of its blockbuster weight-loss shot Wegovy, another effort to counter Eli Lilly & Co. in the booming obesity market.